STYLAGE referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Stylage Bi-Soft XL Lidocaine
Stylage Bi-Soft XL Lidocaine is a volumising hyaluronic acid dermal filler with an anaesthetic by Laboratoires VIVACY, developed for facial volume restoration. It is suitable for authorised medical practitioners to correct visible volume loss and structural sagging in the cheeks, cheekbones and temples, with the gel placed subcutaneously. The product contains cross-linked hyaluronic acid at 26 mg/mL with mannitol (35 mg/g) and 0.3% w/w lidocaine hydrochloride monohydrate and is intended for professional use.
Principales ventajas de Stylage Bi-Soft XL Lidocaine
- Designed for facial volume restoration, with light volume creation also possible
- Provides strong, long-lasting volumising results
- Helps reduce visible signs of facial ageing associated with volume loss and facial sagging
- The first product in VIVACY's volumising range, described as slightly less viscous than STYLAGE XXL
- Suitable for structural facial areas such as the cheeks, cheekbones and temples
- Formulated with 26 mg/mL cross-linked hyaluronic acid in a mannitol-enriched phosphate buffer (35 mg/g)
- Contains lidocaine hydrochloride monohydrate 0.3% w/w for patient comfort during injection
- Supplied in the patented Bi-SOFT injection system, which VIVACY presents as improving precision, grip, stability, injection control and handling
- CE-marked Class III medical device (CE 0344), made in France
Indicaciones y uso profesional
Indicaciones principales
- Facial volume restoration
- Light volume creation
- Correction of age-related volume loss and facial sagging
- Restoration of volume loss or displacement
- Midface remodelling
Uso profesional
Stylage Bi-Soft XL Lidocaine is a Class III medical device (CE 0344), non-reimbursable, and the injection must be administered by a legally authorised practitioner trained in implant injection techniques. VIVACY specifies a subcutaneous injection plan, using linear threading, multipoint injection or a combination of both, with a 27G half-inch or 23G one-and-a-quarter-inch needle, or a cannula whose gauge and length are selected by the practitioner. The lidocaine hydrochloride is intended to reduce the pain related to injection. Patient selection, screening for anaesthetic sensitivity, injection technique and volume per treatment area remain the responsibility of the treating practitioner.
Zonas de tratamiento
- Cheeks
- Cheekbones
- Temples
Perfil del paciente
Suitable for adult patients presenting facial volume loss or displacement, for restoration or augmentation of facial volume in the cheeks, cheekbones and temples. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates. Patients should be counselled that VIVACY lists inflammation, redness, swelling, pain, erythema, induration, nodules, colouration or discolouration and bruising among possible side effects, as a non-exhaustive list. The product is a Class III medical device and is non-reimbursable. Individual suitability and treatment planning are determined by the practitioner.
Cómo funciona Stylage Bi-Soft XL Lidocaine
Stylage Bi-Soft XL Lidocaine works through cross-linked hyaluronic acid at 26 mg/mL, the highest concentration in the range. That is what allows it to project and support tissue from the subcutaneous plane rather than merely fill a line: VIVACY describes a dynamic and smooth projection capacity, a homogeneous gel for regular injection, high cohesivity and slow even degradation. The mannitol-enriched buffer helps protect the hyaluronic acid against degradation, and the lidocaine hydrochloride monohydrate 0.3% w/w acts locally to reduce the pain related to injection.
Por qué comprar en Allpara
Allpara ofrece productos STYLAGE originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
Where is Stylage Bi-Soft XL Lidocaine injected?
It is injected subcutaneously, using linear threading, multipoint injection or a combination of both, with a 27G half-inch or 23G one-and-a-quarter-inch needle, or a cannula whose gauge and length are selected by the practitioner.
Which side effects does VIVACY list?
As a non-exhaustive list: inflammation, redness, swelling, pain, erythema, induration, nodules, colouration or discolouration, and bruising. The product is a Class III medical device and is non-reimbursable. Serious side effects should be reported without delay to Laboratoires VIVACY and to the national health authority of the country in which the patient is established.
How long does Stylage Bi-Soft XL Lidocaine last?
83.8% of patients were still improved at 18 months on GAIS (patient assessment). Separately, the published Beauty Volume study in the cheekbones reported a correction that remained stable over 18 months.
Opiniones de clientes
Más productos de Laboratoires VIVACY
Alternativas para la clínica
Retome donde lo dejó
Stylage Bi-Soft XL Lidocaine
Stylage Bi-Soft XL Lidocaine is a volumising hyaluronic acid dermal filler with an anaesthetic by Laboratoires VIVACY, developed for facial volume restoration. It is suitable for authorised medical practitioners to correct visible volume loss and structural sagging in the cheeks, cheekbones and temples, with the gel placed subcutaneously. The product contains cross-linked hyaluronic acid at 26 mg/mL with mannitol (35 mg/g) and 0.3% w/w lidocaine hydrochloride monohydrate and is intended for professional use.
Principales ventajas de Stylage Bi-Soft XL Lidocaine
- Designed for facial volume restoration, with light volume creation also possible
- Provides strong, long-lasting volumising results
- Helps reduce visible signs of facial ageing associated with volume loss and facial sagging
- The first product in VIVACY's volumising range, described as slightly less viscous than STYLAGE XXL
- Suitable for structural facial areas such as the cheeks, cheekbones and temples
- Formulated with 26 mg/mL cross-linked hyaluronic acid in a mannitol-enriched phosphate buffer (35 mg/g)
- Contains lidocaine hydrochloride monohydrate 0.3% w/w for patient comfort during injection
- Supplied in the patented Bi-SOFT injection system, which VIVACY presents as improving precision, grip, stability, injection control and handling
- CE-marked Class III medical device (CE 0344), made in France
Indicaciones y uso profesional
Indicaciones principales
- Facial volume restoration
- Light volume creation
- Correction of age-related volume loss and facial sagging
- Restoration of volume loss or displacement
- Midface remodelling
Uso profesional
Stylage Bi-Soft XL Lidocaine is a Class III medical device (CE 0344), non-reimbursable, and the injection must be administered by a legally authorised practitioner trained in implant injection techniques. VIVACY specifies a subcutaneous injection plan, using linear threading, multipoint injection or a combination of both, with a 27G half-inch or 23G one-and-a-quarter-inch needle, or a cannula whose gauge and length are selected by the practitioner. The lidocaine hydrochloride is intended to reduce the pain related to injection. Patient selection, screening for anaesthetic sensitivity, injection technique and volume per treatment area remain the responsibility of the treating practitioner.
Zonas de tratamiento
- Cheeks
- Cheekbones
- Temples
Perfil del paciente
Suitable for adult patients presenting facial volume loss or displacement, for restoration or augmentation of facial volume in the cheeks, cheekbones and temples. Because this reference contains an amide-type local anaesthetic, patients with known lidocaine sensitivity are not candidates. Patients should be counselled that VIVACY lists inflammation, redness, swelling, pain, erythema, induration, nodules, colouration or discolouration and bruising among possible side effects, as a non-exhaustive list. The product is a Class III medical device and is non-reimbursable. Individual suitability and treatment planning are determined by the practitioner.
Cómo funciona Stylage Bi-Soft XL Lidocaine
Stylage Bi-Soft XL Lidocaine works through cross-linked hyaluronic acid at 26 mg/mL, the highest concentration in the range. That is what allows it to project and support tissue from the subcutaneous plane rather than merely fill a line: VIVACY describes a dynamic and smooth projection capacity, a homogeneous gel for regular injection, high cohesivity and slow even degradation. The mannitol-enriched buffer helps protect the hyaluronic acid against degradation, and the lidocaine hydrochloride monohydrate 0.3% w/w acts locally to reduce the pain related to injection.
Por qué comprar en Allpara
Allpara ofrece productos STYLAGE originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
Where is Stylage Bi-Soft XL Lidocaine injected?
It is injected subcutaneously, using linear threading, multipoint injection or a combination of both, with a 27G half-inch or 23G one-and-a-quarter-inch needle, or a cannula whose gauge and length are selected by the practitioner.
Which side effects does VIVACY list?
As a non-exhaustive list: inflammation, redness, swelling, pain, erythema, induration, nodules, colouration or discolouration, and bruising. The product is a Class III medical device and is non-reimbursable. Serious side effects should be reported without delay to Laboratoires VIVACY and to the national health authority of the country in which the patient is established.
How long does Stylage Bi-Soft XL Lidocaine last?
83.8% of patients were still improved at 18 months on GAIS (patient assessment). Separately, the published Beauty Volume study in the cheekbones reported a correction that remained stable over 18 months.